Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
NCT00004102 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00004102 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer |
| Official title | A Phase II Trial of Eloxatin in Combination With 5-Fluorouracil and Leucovorin in Patients With Advanced Colorectal Carcinoma |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | FOLFOX regimen, fluorouracil, leucovorin calcium, oxaliplatin |
| Start date | Jan 1, 1999 |
| Primary completion | Nov 1, 2001 |
| First posted | Apr 12, 2004 |
| Last update posted | Mar 28, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: